WO2004087630A1 - Process for producing cyclohexenone long-chain alcohols - Google Patents

Process for producing cyclohexenone long-chain alcohols Download PDF

Info

Publication number
WO2004087630A1
WO2004087630A1 PCT/JP2003/003994 JP0303994W WO2004087630A1 WO 2004087630 A1 WO2004087630 A1 WO 2004087630A1 JP 0303994 W JP0303994 W JP 0303994W WO 2004087630 A1 WO2004087630 A1 WO 2004087630A1
Authority
WO
WIPO (PCT)
Prior art keywords
mmol
cyclohexen
methyl
cyclohexenone long
chain alcohol
Prior art date
Application number
PCT/JP2003/003994
Other languages
French (fr)
Inventor
Bang Luu
Patrick Neuberg
Delphine Trancard
Masashi Yamada
Yukio Oshiba
Hiroto Suzuki
Original Assignee
Meiji Dairies Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corporation filed Critical Meiji Dairies Corporation
Priority to PCT/JP2003/003994 priority Critical patent/WO2004087630A1/en
Priority to CA002519178A priority patent/CA2519178C/en
Priority to US10/550,305 priority patent/US7235700B2/en
Priority to DE60319439T priority patent/DE60319439T2/en
Priority to EP03715611A priority patent/EP1608612B1/en
Publication of WO2004087630A1 publication Critical patent/WO2004087630A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/713Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups a keto group being part of a six-membered ring

Definitions

  • the present invention relates to a process for producing a cyclohexenone long-chain alcohol, which process requires a reduced number of reaction steps and can be performed with ease and is thus industrially advantageous.
  • Nerve growth factor which is found in particular abundance in the hippocampus and cerebral cortex of the brain, is a neurotrophic factor which is required by a living body for sustaining life and functions and stimulates differentiation and growth of neurons.
  • NGF acts on cholinergic neurons. Alzheimer's disease is accepted to exhibit a primary lesion of regeneration and falling of cholinergic neurons, and on the basis of this understanding, NGF has been administered to the brain as therapy for the disease.
  • NGF being a protein having a molecular weight of 12,000, cannot pass through the blood-brain barrier, and thus does not serve as practical means for the treatment of Alzheimer's disease.
  • cyclohexenone long-chain alcohol has a low molecular weight and is known to be useful as a prophylactic or therapeutic drug for cerebral diseases such as dementia, in view that, when administered orally, the alcohol reaches the brain, passes through the blood-brain barrier, and at low concentration exhibits excellent effect to stimulate growth of neurons, to thereby directly act on neurites to elicit extension (Japanese Kohyo (PCT) Patent Publication No. 2U01- 515058) .
  • cyclohexenone long-chain alcohol has been produced through a complicated process; for example, by reacting cyclohexanone or methyl-substituted 2-cyclohexen-l- one with benzenesulfinate in the presence of acid, then with ethylene glycol to form a ketal compound, and further with ⁇ -halogenoalcanol, followed by treatment with an acid to remove a protective group.
  • cyclohexanone or methyl-substituted 2-cyclohexen-l- one with benzenesulfinate in the presence of acid, then with ethylene glycol to form a ketal compound, and further with ⁇ -halogenoalcanol, followed by treatment with an acid to remove a protective group.
  • 3- (14-hydroxytetradecyl) -4-methyl-2-cyclohexen- 1-one from a starting material 3-methylcyclohexenone
  • seven reaction steps have conventionally been required.
  • an object of the present invention is to provide an industrially advantageous process for producing cyclohexenone long-chain alcohol, which process requires a reduced number of reaction steps and can be performed with ease ' and at reduced production cost.
  • the present inventors have performed extensive studies for developing a simple, convenient process for producing cyclohexenone long-chain alcohol starting from a known substance, and have found that when cyclohexenone of enol form which can be produced with ease from a known substance 1, 3-cyclohexanedione is subjected to Grignard reaction by use of ⁇ -halogeno long-chain alcohol whose hydroxyl group is protected through silylation, cyclohexenone long-chain alcohol can be obtained through a reduced number of steps, conveniently, at low production cost, and in an industrially advantageous manner, thus leading to completion of the invention.
  • the present invention provides a process for producing cyclohexenone long-chain alcohol represented by the following formula (1) :
  • R 1 , R 2 , and R 3 have the same meanings as above, and R 4 represents a C1-C5 alkyl group
  • a Grignard's reagent prepared from C10-C18 ⁇ -halogenoalcohol whose hydroxyl group is protected through silylation, and hydrolyzing the resultant reaction product.
  • each of R 1 , R 2 , and R 3 represents a hydrogen atom.
  • at least one of these is methyl.
  • R 4 represents a C1-C5 alkyl, with ethyl being particularly preferred.
  • Examples of preferred starting compound (2) include 3- ethoxy-6-methyl-2-cyclohexen-l-one, 3-ethoxy-2, 6-dimethyl-2- cyclohexen-1-one, and 3-methoxy-2, 6, ⁇ -trimethyl-2-cyclohexen- 1-one.
  • the starting compound (2) can be obtained through enolation and methylation of 1, 3-cyclohexanedione, which is available at low cost.
  • the sequence in which enolation and methylation are carried out is not critical, and enolation may precede methylation or vice versa.
  • R 1 , R 2 , and R 3 are hydrogen atoms, methylation is not necessary.
  • Enolation may be performed by reacting 1,3- cyclohexanedione, which may optionally be methylated if necessary (e.g., 2-methyl-l, 3-cyclohexanedione) , with alcohol (R 4 OH) in the presence of an acid catalyst.
  • the acid catalyst include p-toluenesulfonic acid and sulfuric acid.
  • the reaction is carried out in a solvent such as toluene, xylene, methanol, or ethanol, at 60-150°C for 2 to 10 hours.
  • Methylation is performed by, for example, reacting enolated 1, 3-cyclohexanedione, which may optionally be enolated if necessary, with a lithiation reagent such as lithium diisopropylamide obtained through reaction between alkyl lithium and diisopropylamine, then with a methylation agent such as methyl iodide.
  • a lithiation reagent such as lithium diisopropylamide obtained through reaction between alkyl lithium and diisopropylamine
  • the lithiation reaction is preferably performed by cooling a solution prepared by adding lithium diisopropylamine to tetrahydrofuran or hexane to -80 to 0°C (e.g., -78°C) , then adding optionally enolated 1,3- ' cyclohexanedione (preferably 3-ethoxy-2-cyclohexan-l-one) dissolved in tetrahydrofuran, hexane, etc.
  • methylation is performed after adding methyl iodide to the resultant reaction mixture and heating the mixture to 5 to 30°C (e.g., room temperature), while stirring the mixture for 5 to 12 hours.
  • the thus-obtained compound (2) is reacted with a Grignard's reagent prepared from C10-C18 ⁇ -halogenoalcanol whose hydroxy group is protected through silylation, and is then subjected to hydrolysis, to thereby produce a cyclohexenone long-chain alcohol (1) .
  • a Grignard's reagent prepared from C10-C18 ⁇ -halogenoalcanol whose hydroxy group is protected through silylation, and is then subjected to hydrolysis, to thereby produce a cyclohexenone long-chain alcohol (1) .
  • Examples of the C10- C18 ⁇ -halogenoalcanol which has undergone silylation include the compound represented by the following formula (3) :
  • R 5 , R 6 , and R 7 represents a C1-C8 alkyl group)'.
  • X include Cl, Br, and I, with Br being preferred.
  • A include C10-C18 linear or branched alkylene or alkenylene groups, with C12-C16 linear or branched alkylene groups being more preferred, and C12-C16 linear alkylene groups being even more preferred, and tetradecylene and pentadecylene being most preferred.
  • R 5 , R 6 , and R 7 include a methyl group, an ethyl group, an isopropyl group, and a t-butyl group.
  • the Grignard's reagent used in the present invention can be obtained by a conventional method, through reaction between a silylated ⁇ -halogenoalcanol and magnesium.
  • the reaction between the compound (2) and the Grignard's reagent is performed in the manner of an ordinary Grignard reaction, and preferably in an absolute solvent such as diethyl ether or tetrahydrofuran at 40-80°C for 0.5 to 3 hours .
  • the subsequent hydrolysis is preferably performed in the presence of an acid such as p-toluenesulfonic acid, hydrochloric acid, or sulfuric acid.
  • an acid such as p-toluenesulfonic acid, hydrochloric acid, or sulfuric acid.
  • the resultant intermediate may be isolated and then forwarded to the next reaction step.
  • the intermediate may be forwarded directly to the next reaction step, without being isolated.
  • the intermediate or a target compound can be isolated from a reaction mixture through washing, extraction, recrystallization, chromatographic techniques, etc., solely or in combination.
  • methyl iodide (1.21 mL, 19.45 mmol) was added thereto, and the temperature of the reaction mixture was allowed to rise to room temperature.
  • the reaction mixture was stirred overnight, diluted with water (100 mL) , and then extracted three times with ethyl ether. The organic layers were combined, washed with an aqueous NaCl solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
  • Hydrogen bromide 50 L was gradually added to a mixture of 1, 15-pentadecanediol (5.08 g, 20.8 mmol) and cyclohexane (50 mL) , and the resultant mixture was refluxed with heat for 6 hours, followed by separation into two layers, The aqueous layer was subjected to extraction with hexane three times. The organic layers were combined, washed with aqueous saturated sodium hydrogencarbonate solution and aqueous sodium chloride solution, dried over magnesium sulfate, and concentrated under reduced pressure.
  • the mixture was stirred for one hour at room temperature.
  • aqueous saturated ammonium chloride solution was added to the reaction mixture for separation into a methylene chloride layer (200 mL) and an aqueous layer (200 . mL) .
  • the organic layer was dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
  • the reaction mixture was neutralized with sodium hydrogencarbonate, followed by extraction with ethyl ether three times.
  • the organic layers were combined, washed with aqueous sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
  • methyl iodide (0.77 mL, 12.4 mmol) was added, and the temperature of the reaction mixture was allowed to rise to room temperature. The reaction mixture was stirred for 18 hours at room temperature. Water (100 mL) was added thereto, and the resultant mixture was subjected to extraction three times with ethyl ether. The organic layers were combined, washed with an aqueous NaCl solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
  • the process of the present invention for producing cyclohexenone long-chain alcohol involves a reduced number of reaction steps, can be performed with ease at reduced production cost, and thus finds utility in the industry.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process for producing cyclohexenone long-chain alcohol represented by the following formula (1): (wherein A represents a C10-C18 alkylene or alkenylene group, and each of R1, R2, and R3 individually represents hydrogen or methyl), comprising reacting a 3-alkoxy-2-cyclohexen-1-one derivative represented by the following formula (2): (wherein R1, R2, and R3 have the same meanings as above, and R4 represents a C1-C5 alkyl group) with a Grignard's reagent prepared by protecting the hydroxyl groups of C10-C18 ω-halogenoalcohol through silylation, and hydrolyzing the resultant reaction product. The process of the present invention for producing cyclohexenone long-chain alcohol requires a reduced number of reaction steps, can be performed with ease and with reduced production cost, and thus finds utility in the industry.

Description

DESCRIPTION
PROCESS FOR PRODUCING CYCLOHEXENONE LONG-CHAIN ALCOHOLS
Technical Field
The present invention relates to a process for producing a cyclohexenone long-chain alcohol, which process requires a reduced number of reaction steps and can be performed with ease and is thus industrially advantageous.
Background Art
Nerve growth factor (NGF) , which is found in particular abundance in the hippocampus and cerebral cortex of the brain, is a neurotrophic factor which is required by a living body for sustaining life and functions and stimulates differentiation and growth of neurons. In the brain, NGF acts on cholinergic neurons. Alzheimer's disease is accepted to exhibit a primary lesion of regeneration and falling of cholinergic neurons, and on the basis of this understanding, NGF has been administered to the brain as therapy for the disease.
However, NGF, being a protein having a molecular weight of 12,000, cannot pass through the blood-brain barrier, and thus does not serve as practical means for the treatment of Alzheimer's disease.
Meanwhile, cyclohexenone long-chain alcohol has a low molecular weight and is known to be useful as a prophylactic or therapeutic drug for cerebral diseases such as dementia, in view that, when administered orally, the alcohol reaches the brain, passes through the blood-brain barrier, and at low concentration exhibits excellent effect to stimulate growth of neurons, to thereby directly act on neurites to elicit extension (Japanese Kohyo (PCT) Patent Publication No. 2U01- 515058) .
Hitherto, cyclohexenone long-chain alcohol has been produced through a complicated process; for example, by reacting cyclohexanone or methyl-substituted 2-cyclohexen-l- one with benzenesulfinate in the presence of acid, then with ethylene glycol to form a ketal compound, and further with ω-halogenoalcanol, followed by treatment with an acid to remove a protective group. Specifically, in the case of production of 3- (14-hydroxytetradecyl) -4-methyl-2-cyclohexen- 1-one from a starting material 3-methylcyclohexenone, seven reaction steps have conventionally been required.
Disclosure of the Invention
As described above, the conventional process for producing cyclohexenone long-chain alcohol requires a number of complicated and intricate steps, involves high production cost, and is thus industrially disadvantageous.
Accordingly, an object of the present invention is to provide an industrially advantageous process for producing cyclohexenone long-chain alcohol, which process requires a reduced number of reaction steps and can be performed with ease' and at reduced production cost. The present inventors have performed extensive studies for developing a simple, convenient process for producing cyclohexenone long-chain alcohol starting from a known substance, and have found that when cyclohexenone of enol form which can be produced with ease from a known substance 1, 3-cyclohexanedione is subjected to Grignard reaction by use of ω-halogeno long-chain alcohol whose hydroxyl group is protected through silylation, cyclohexenone long-chain alcohol can be obtained through a reduced number of steps, conveniently, at low production cost, and in an industrially advantageous manner, thus leading to completion of the invention.
Accordingly, the present invention provides a process for producing cyclohexenone long-chain alcohol represented by the following formula (1) :
Figure imgf000004_0001
(wherein A represents a C10-C18 alkylene or alkenylene group, and each of R1, R2, and R3 individually represents a hydrogen atom or a methyl group) , comprising reacting a 3-alkoxy-2- cyclohexen-1-one derivative represented by the following formula (2) :
Figure imgf000005_0001
(wherein R1, R2, and R3 have the same meanings as above, and R4 represents a C1-C5 alkyl group) with a Grignard's reagent prepared from C10-C18 ω-halogenoalcohol whose hydroxyl group is protected through silylation, and hydrolyzing the resultant reaction product.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
In the starting compound represented by formula (2) (hereinafter referred to as compound (2) ) , each of R1, R2, and R3 represents a hydrogen atom. Preferably, at least one of these is methyl. The following cases are particularly preferred: R1 = CH3 and R2 = R3 = H, or R1 = R2 = R3 = CH3. R4 represents a C1-C5 alkyl, with ethyl being particularly preferred.
Examples of preferred starting compound (2) include 3- ethoxy-6-methyl-2-cyclohexen-l-one, 3-ethoxy-2, 6-dimethyl-2- cyclohexen-1-one, and 3-methoxy-2, 6, β-trimethyl-2-cyclohexen- 1-one.
The starting compound (2) can be obtained through enolation and methylation of 1, 3-cyclohexanedione, which is available at low cost. The sequence in which enolation and methylation are carried out is not critical, and enolation may precede methylation or vice versa. When all of R1, R2, and R3 are hydrogen atoms, methylation is not necessary.
Enolation may be performed by reacting 1,3- cyclohexanedione, which may optionally be methylated if necessary (e.g., 2-methyl-l, 3-cyclohexanedione) , with alcohol (R4OH) in the presence of an acid catalyst. Examples of the acid catalyst include p-toluenesulfonic acid and sulfuric acid. The reaction is carried out in a solvent such as toluene, xylene, methanol, or ethanol, at 60-150°C for 2 to 10 hours.
Methylation is performed by, for example, reacting enolated 1, 3-cyclohexanedione, which may optionally be enolated if necessary, with a lithiation reagent such as lithium diisopropylamide obtained through reaction between alkyl lithium and diisopropylamine, then with a methylation agent such as methyl iodide. The lithiation reaction is preferably performed by cooling a solution prepared by adding lithium diisopropylamine to tetrahydrofuran or hexane to -80 to 0°C (e.g., -78°C) , then adding optionally enolated 1,3- ' cyclohexanedione (preferably 3-ethoxy-2-cyclohexan-l-one) dissolved in tetrahydrofuran, hexane, etc. Preferably, methylation is performed after adding methyl iodide to the resultant reaction mixture and heating the mixture to 5 to 30°C (e.g., room temperature), while stirring the mixture for 5 to 12 hours.
The thus-obtained compound (2) is reacted with a Grignard's reagent prepared from C10-C18 ω-halogenoalcanol whose hydroxy group is protected through silylation, and is then subjected to hydrolysis, to thereby produce a cyclohexenone long-chain alcohol (1) . Examples of the C10- C18 ω-halogenoalcanol which has undergone silylation include the compound represented by the following formula (3) :
RD
X—A—O—Si-Rb ( 3 ) R7
(wherein X represents a halogen atom, A represents a
C10-C18 alkylene or alkenylene group, and each of R5, R6, and R7 represents a C1-C8 alkyl group)'. Examples of X include Cl, Br, and I, with Br being preferred. Examples of A include C10-C18 linear or branched alkylene or alkenylene groups, with C12-C16 linear or branched alkylene groups being more preferred, and C12-C16 linear alkylene groups being even more preferred, and tetradecylene and pentadecylene being most preferred. Examples of R5, R6, and R7 include a methyl group, an ethyl group, an isopropyl group, and a t-butyl group. The Grignard's reagent used in the present invention can be obtained by a conventional method, through reaction between a silylated ω-halogenoalcanol and magnesium.
The reaction between the compound (2) and the Grignard's reagent is performed in the manner of an ordinary Grignard reaction, and preferably in an absolute solvent such as diethyl ether or tetrahydrofuran at 40-80°C for 0.5 to 3 hours .
The subsequent hydrolysis is preferably performed in the presence of an acid such as p-toluenesulfonic acid, hydrochloric acid, or sulfuric acid. Through hydrolysis, the group R4, the Grignard's reagent, and the silylation- protective group are removed.
In each reaction step of the process of the present invention, the resultant intermediate may be isolated and then forwarded to the next reaction step. However, the intermediate may be forwarded directly to the next reaction step, without being isolated. In the present invention, the intermediate or a target compound can be isolated from a reaction mixture through washing, extraction, recrystallization, chromatographic techniques, etc., solely or in combination.
Examples
The present invention will next be described by way of Examples, which should not be construed as limiting the invention thereto.
Example 1 Synthesis of 3- (15-hydroxypentadecyl) -2, 4, 4- trimethyl-2-cyclohexen-1-one
(1) Synthesis of 3-ethoxy-2-methyl-2-cyclohexen-l-one : 2-Methyl-l, 3-cyclohexanedione (3g, 23.8 mmol) was dissolved in a mixture of ethanol (30 mL) and toluene (56 L) , and to the resultant mixture, p-toluenesulfonic acid (92 mg, 0.47 mmol) was added. The mixture was allowed to react while refluxing with heat. Subsequently, the water/ethanol/toluene azeotrope (boiling point: 78°C) was distilled off, and the remaining toluene was removed under reduced pressure. The crude product was purified by silica gel flash chromatography (ethyl ether/hexane = 8/2), to thereby yield 2.7 g (17.4 mmol) of 3-ethoxy-2-methyl-2-cyclohexen-l-one.
Yield: 73%
Rf (ethyl ether/hexane = 80/20) = 0.37
Η-NMR (200MHz, CDC13) δ : 1.32 (t, 3J=7.00Hz, 3H, H-9) , 1.67 (t, 4J=1.49Hz, 3H,
H-7) , 1.94 (qn, 3J=6.33Hz, 2H, H-5) , 2.31 (t, 3J=6.62Hz, 2H, H-6) , 2.51 (td, 3J=6.12
Hz, J=1.44Hz, 2H, H-4) , 4.03 (q, 3J=7.00Hz, 2H, H-8) . 13C-NMR (50MHz, CDCI3) δ : 7.4 (C-7) , 15.4(C-9), 21.1(C-5),
25.4(C-4), 36.4(C-6), 63.5(C-8), 115.1(C-2), 171.4(C-3),
198.9(C-1) .
(2) Synthesis of 3-ethoxy-2, β-dimethyl-2-cyclohexen-l-one: Diisopropylamine (2.35 mL, 19.45 mmol) dissolved in tetrahydrofuran (8 mL) was cooled to -78°C, n-butyllithium (12.96 mL, 19.45 mmol) was added thereto, and the temperature was elevated to 0°C. After having been stirred for 2 hours at 0°C, the reaction mixture was cooled to -78°C, and 3- ethoxy-2-methyl-2-cyclohexen-l-one (2 g, 12.96 mmol) dissolved in tetrahydrofuran (5 mL) was added thereto. One hour later, methyl iodide (1.21 mL, 19.45 mmol) was added thereto, and the temperature of the reaction mixture was allowed to rise to room temperature. The reaction mixture was stirred overnight, diluted with water (100 mL) , and then extracted three times with ethyl ether. The organic layers were combined, washed with an aqueous NaCl solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was applied to silica, and purified by means of silica gel column chromatography (ethyl ether/hexane = 4/6), to thereby yield 1.72 g (10.24 mmol) of 3-ethoxy-2, 6-dimethyl-2-cyclohexen-l-one.
Yield: 79%
Rf (ethyl ether/hexane = 40/60) = 0.9
JH-NMR (200MHz, CDC13) δ : 1.12 (d, 3H, H-8) , 1.33 (t, 3J=7.00Hz, 3H, H-10) , 1.5 4-1.74 (m, 4H, H-5, H-7), 1.98-2.11 (m, IH, H-5'), 2.19-2.31 (m, IH, H-6), 2.51-2.6 0 (m, 2H, H-4) , 4.04 (qd, J=4.68Hz, J=2.33Hz, 2H, H-9) .
13C-NMR(50MHz,CDCl3) δ : 7.4(C-7), 15.3 and 15.7(C-8, C-10), 24.5(C-5), 28.9(C-4), 39.5(C-6), 63.3(C-9), 114.3(C-2), 170.2(C-3), 201.2(C-1).
(3) Synthesis of 3-ethoxy-2, 6, 6-trimethyl-2-cyclohexen-l- one :
Diisopropylamine (1.45 mL, 10.34 mmol) dissolved in tetrahydrofuran (3 L) was cooled to -78°C, n-butyllithium (8.7 mL, 10.46 mmol) was added thereto, and the temperature was elevated to 0°C. After having been stirred fo'r 2 hours at 0°C, the reaction mixture was cooled to -78°C, and 3- ethoxy-2, 6-dimethyl-2-cyclohexen-l-one (1.47 g, 8.72 mmol) dissolved in tetrahydrofuran (6 mL) was added thereto. One hour later, methyl iodide (1.59 mL, 10.46 mmol) was added thereto, and the temperature of the reaction mixture was allowed to rise to room temperature. The reaction mixture was stirred overnight, diluted with water (100 mL) , and then extracted three times with ethyl ether. The organic layers were combined, washed with an aqueous NaCl solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. ■ The crude product was purified by silica gel column chromatography (ethyl ether/hexane = 4/6) , to thereby yield 1.46 g (8.04 mmol) of 3-ethoxy-2, 6, 6-trimethyl- 2-cyclohexen-l-one .
Yield: 92.2% Rf (ethyl ether/hexane = 40/60) = 0.31
Η-NMR (200MHz, CDC13) δ : 1.03(s,6H,H-8,H-9), 1.30 (t, 3J=7.01Hz, 3H, H-ll), 1 .64 (t, 4J=1.6Hz, 3H, H-7) , 1.75 (t, 3J=6.27Hz, 2H, H-5) , 2.51 (tq, 3J=6.29Hz, J=1.5 6Hz, 2H, H-4) , 4.01 (q, 3J=6.97Hz, 2H, H-10) .
13C-NMR(50MHz,CDCl3) δ :8.0(C-7), 15.4(0-11), 22.6(C-4), 24.7 (C-8, C-9) , 34.7(C-5), 39.5(C-6), 63.2(C-10), 113. l(C-2), 169.0(C-3), 203.6(C-1).
(4) Synthesis of 15-bromo-l- (t-butyldimethylsiloxy) - pentadecane
(a) Synthesis of 1, 15-pentadecanediol Pentadecanolide (5 g, 20.8 mmol) dissolved in tetrahydrofuran (150 mL) was cooled to 0°C, and to the resultant solution, aluminum lithium hydride (1.2 g, 31.2 mmol) was added in portions. The temperature of the mixture was then returned to room temperature. The reaction mixture was stirred for three days at room temperature, and subsequently, an aqueous saturated tartaric acid solution (200 mL) was added thereto at 0°C. The mixture was subjected to extraction with ethyl ether three times. The organic layers were combined, washed with aqueous sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure, to thereby yield 5.01 g (20.5 mmol) of 1, 15-pentadecanediol .
Yield: 98.6%
Rf (hexane/ethyl acetate = 10/90) = 0 . 44 Melting point : 84 - 85°C Η-NMR (200MHz, CDClg) δ : 1. 28 (s large, 22H, H-3 to H-13) , 1. 56 (qn, 3J=6. 6Hz,
4H. H-2, 14) , 3. 64 (t, 3J=6. 6Hz, 4H, H-l, 15) .
13C-NMR(50MHz, CDCI3) δ : 26. 5 (03, 13) , 29. 9 (C-4 to C-12) , 33. 7 (C-2, C-14) , 62. 1 (0-1, 15) .
(b) Synthesis of 15-bromo-pentadecan-l-ol
48% Hydrogen bromide (50 L) was gradually added to a mixture of 1, 15-pentadecanediol (5.08 g, 20.8 mmol) and cyclohexane (50 mL) , and the resultant mixture was refluxed with heat for 6 hours, followed by separation into two layers, The aqueous layer was subjected to extraction with hexane three times. The organic layers were combined, washed with aqueous saturated sodium hydrogencarbonate solution and aqueous sodium chloride solution, dried over magnesium sulfate, and concentrated under reduced pressure. The crude product was applied to silica for purification by means of silica gel column chromatography (hexane/ethyl acetate = 7/3) , to thereby yield 4.33 g (14.08 mmol) of 15-bromo-pentadecan- l-ol.
Yield: 68%
Rf (hexane/ethyl acetate = 60/40) = 0.47 Melting point: 61 - 63°C
!H-NMR (200MHz, CDClg) δ : 1.28(s large, 22H, H-3 to H-13), 1.57 (qn, 3J=6.7Hz, 2H.H-2), 1.86(qn,3J=6.8Hz, 2H.H-14), 3.41 (t, 3J=6.8Hz, 2H, H~15), 3.65(t,3J=6. 6Hz, 2H, H-l) .
13C-NMR(50MHz,CDCl3) δ : 25.5(C-3), 28.1(C-13), 28.5(C-12), 29.4(C-4 to C-ll), 32.7(C-2,C-15), 33.8(C-14), 62.9(C-1).
(c) Synthesis of 15-bromo-l- (t-butyldimethylsiloxy) - pentadecane
15-Bromo-pentadecan-l-ol (2.3 g, 7.49 mmol) dissolved in methylene chloride (23 mL) was mixed with trimethylamine
(2.1 mL, 14.98 mmol), t-butyldimethylsilyl chloride (2.03 g,
13.48 mmol), and dimethylaminopyridine (457.6 mg, 3.74 mmol).
The mixture was stirred for one hour at room temperature.
Subsequently, aqueous saturated ammonium chloride solution was added to the reaction mixture for separation into a methylene chloride layer (200 mL) and an aqueous layer (200 . mL) . The organic layer was dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by means of silica gel column flash chromatography (hexane/ethyl acetate = 99/1) , to thereby afford 2.98 g (7.07 mmol) of 15-bromo-l- (t- butyldimethylsiloxy) pentadecane .
Yield: 94.4%
Rf (hexane = 100) = 0.43
Η-NMR (200MHz, CDC13) δ : 0.00 (s, 6H, Me) , 0.85 (s, 9H, tBu) , 1.21 (s large, 22H, H-3 to H-13), 1.33-1.46(m, 2H.H-2), 1.74-1.88 (m, 2H, H-14), 3.36(t, 3J=6.89Hz , 2H, H-15) , 3.55 (t, 3J=6.52Hz, 2H, H-l) .
13C-NMR(50MHz, CDCI3) δ :-5.2(Me), 26 (tBu), 28.2-29.7(C-3 to C-13), 33 (C- 15), 35 (C-2, C-14) , 63 (CM).
(5) Synthesis of 3- (15-hydroxypentadecyl) -2, 4, 4-trimethyl-2~ cyclohexen-1-one
15-Bromo-l- (t-butyldimethylsiloxy) pentadecane (1 g, 2.36 mmol) dissolved in absolute ethyl ether (3 mL) and magnesium (0.115 g) were mixed, and the mixture was refluxed for 40 minutes. Subsequently, 3-ethoxy-2, 6, 6-trimethyl-2- cyclohexen-1-one (287.5 mg, 1.57 mmol) dissolved in tetrahydrofuran (2 mL) was added thereto. After stirring the mixture for four hours, 10% hydrochloric acid (3 mL) was added, and the reaction was allowed to continue for a further 17 hours under stirring. The reaction mixture was neutralized with sodium hydrogencarbonate, followed by extraction with ethyl ether three times. The organic layers were combined, washed with aqueous sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by means of silica gel column chromatography (hexane/ethyl acetate = 9/1 - 6/4; concentration gradient = 5%), to thereby afford 222.7 mg (0.61 mmol) of 3- (15-hydroxypentadecyl) - 2,4, 4-trimethyl-2-cyclohexen-l-one.
Yield: 39% Rf (hexane/ethyl acetate = 70/30) = 0.26
Melting point: 29 - 30°C
Η-NMR (200MHz, CDClg) δ : 1.06(s,6H,H-22,23), 1.17 (m, 24H, H-8 a H-19), 1.47
On, 2H.H-20), 1.68(s, 3H.H-24), 1.72(t, J=7.14Hz, 2H.H-5), 2.07 (m, 2H, H-7) , 2.
33 (t, J=6.9Hz, 2H, H-6) , 3.55 (t, J=6.64Hz, 2H, H-21) . 13C-NMR (50MHz, CDC13) δ : 11.4 (C-24) , 25.8 (C-19) , 26.8 (C-22, 23) , 28.8 (C-8)
, 29.2-29.6 (C-10 a C-18), 30.5(C-7), 30.9(C-9), 32.7(C-20), 34.2(C-5), 36
.2(C-4), 37.4(C-6), 62.8(C-21), 130.5(C-2), 165.6(C-3), 199. l(C-l).
Example 2 Synthesis of 3- (14-hydroxytetradecyl) -4-methyl-2- cyclohexen-1-one
(1) Synthesis of 3-ethoxy-6-methyl-2-cyclohexen-l-one : Diisopropylamine (3.4 mL, 24.4 mmol) dissolved in tetrahydrofuran (50 mL) was cooled to -78°C, n-butyllithium (8.2 L, 12.3 mmol) was added thereto, and the temperature was elevated to 0°C. After having been stirred for 2 hours at 0°C, the reaction mixture was cooled to -78°C, and 3- ethoxy-2-cyclohexen-l-one (1.54 g, 11 mmol) dissolved in tetrahydrofuran (3 mL) was added thereto. After 2 hours of reaction, methyl iodide (0.77 mL, 12.4 mmol) was added, and the temperature of the reaction mixture was allowed to rise to room temperature. The reaction mixture was stirred for 18 hours at room temperature. Water (100 mL) was added thereto, and the resultant mixture was subjected to extraction three times with ethyl ether. The organic layers were combined, washed with an aqueous NaCl solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure.
The crude product was purified by flash chromatography (ethyl ether/hexane = 40/60), to thereby yield 1.19 g (7.7 mmol) of 3-ethoxy-6-methyl-2-cyclohexen-l-one.
Yield: 73%
Rf (hexane/ethyl acetate = 70/30 ) = 0 . 41
Η-NMR (200MHz, CDClg) δ : 1. 13 (d, 3J=6. 87Hz, 3H, H-7) , 1. 33 (t, 3J=7. 01Hz, 3H, 0C
H2CH3) , 1. 68 (m, 1H. H-5) , 2. 03 (m, IH, H-5') , 2. 26 (m, IH, H-6) , 2. 39 (m, 2H, H-4) , 3
. 85 (q, 3J=7. 04Hz, 2H, 0CH2CH3) , 5. 28 (s, IH, H-2) . 13C-NMR (50MHz, CDC13) δ : 15. 03 (C-7) , 16. 28 (OCH2CH3) , 29. 33 (C-4) , 30. 18 (C-5
) , 41. 03 (C-6) , 65. 06 (0CH2CH3) , 102. 92 (C~2) , 177. 75 (0-3) , 202. 86 (C-1) .
(2) Synthesis of 3- (14-hydroxytetradecyl) -4-methyl-2- cyclohexen-1-one : 14-Bromo-l- (t-butyldimethylsiloxy) tetradecane (1.814 g, 4.45 mmol) dissolved in absolute ethyl ether (4 mL) and magnesium (0.216 g, 8.9 mmol) were mixed, and dibromoethane was added dropwise to the resultant mixture, to thereby initiate Grignard reaction. The reaction was allowed to continue for 30 minutes. 3-Ethoxy-6-methyl-2-cyclohexen-l- one (0.825 g, 5.32 mmol) dissolved in tetrahydrofuran (4 mL) was added thereto. The mixture was stirred for 24 hours at room temperature. Subsequently, 10% hydrochloric acid (10 mL) was added for reaction under stirring for a further 24 hours. The reaction mixture was neutralized with saturated sodium hydrogencarbonate solution (10 mL) then subjected to extraction with ethyl ether (15 mL) three times. The organic layers were combined, washed with an aqueous NaCl solution, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by means of flash chromatography (ethyl ether/hexane = 70/30), to thereby yield 0.768 g (2.74 mmol) of 3- (14- hydroxytetradecyl) -4-methyl-2-cyclohexen-l-one .
Yield: 55%
Rf (ethyl ether/hexane = 70/30) = 0.30 Melting point: 37 - 38°C
Η-NMR (200MHz, CDC13) δ : 1.18 (d, 3J=7.13Hz, 3H, H-21) , 1.25-1.59 (m, 24H, H-8 t o H-19) , 1.69-1.84 (m, IH, H-5) , 2.01-2.57 (m, 6H, H-5' H-7/H-6 H-7'/H-4/H-6') , 3.63 (t, 3J=6.50Hz, 2H, H-20) , 5.80 (s, IH, H-2) .
13C-NMR(50MHz,CDCl3) δ : 17.82(0-21), 25.76(0-5), 27.20-32.82 (C-8 to C-19 ), 33.07(0-4), 34.23(0-7), 35.67(C-6), 63.07(C-20), 124.92(0-2), 170.72 ( C-3), 199.82(0-1). Industrial Applicability
The process of the present invention for producing cyclohexenone long-chain alcohol involves a reduced number of reaction steps, can be performed with ease at reduced production cost, and thus finds utility in the industry.

Claims

Claims
1. A process for producing cyclohexenone long-chain alcohol represented by the following formula (1) :
Figure imgf000019_0001
(wherein A represents a C10-C18 alkylene or alkenylene group, and each of R1, R2, and R3 individually represents a hydrogen atom or a methyl group) , comprising reacting a 3-alkoxy-2- cyclohexen-1-one derivative represented by the following formula (2) :
Figure imgf000019_0002
(wherein R1, R2, and R3 have the same meanings as above, and R4 represents a C1-C5 alkyl group) with a Grignard's reagent prepared from C10-C18 ω-halogenoalcohol whose hydroxyl group is protected through silylation, and hydrolyzing the resultant reaction product.
PCT/JP2003/003994 2003-03-28 2003-03-28 Process for producing cyclohexenone long-chain alcohols WO2004087630A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/JP2003/003994 WO2004087630A1 (en) 2003-03-28 2003-03-28 Process for producing cyclohexenone long-chain alcohols
CA002519178A CA2519178C (en) 2003-03-28 2003-03-28 Process for producing cyclohexenone long-chain alcohols
US10/550,305 US7235700B2 (en) 2003-03-28 2003-03-28 Process for producing cyclohexenone long-chain alcohols
DE60319439T DE60319439T2 (en) 2003-03-28 2003-03-28 METHOD FOR THE PRODUCTION OF LONG-CHAIN CYCLOHEXENONAL COLKS
EP03715611A EP1608612B1 (en) 2003-03-28 2003-03-28 Process for producing cyclohexenone long-chain alcohols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2003/003994 WO2004087630A1 (en) 2003-03-28 2003-03-28 Process for producing cyclohexenone long-chain alcohols

Publications (1)

Publication Number Publication Date
WO2004087630A1 true WO2004087630A1 (en) 2004-10-14

Family

ID=33105315

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/003994 WO2004087630A1 (en) 2003-03-28 2003-03-28 Process for producing cyclohexenone long-chain alcohols

Country Status (5)

Country Link
US (1) US7235700B2 (en)
EP (1) EP1608612B1 (en)
CA (1) CA2519178C (en)
DE (1) DE60319439T2 (en)
WO (1) WO2004087630A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180108669A (en) * 2016-01-22 2018-10-04 다이호야쿠힌고교 가부시키가이샤 Process for producing high purity cyclohexenone long-chain alcohol
RU2745062C2 (en) * 2016-02-03 2021-03-18 Тайхо Фармасьютикал Ко., Лтд. Producing method of long-chain alcohol of high purity cyclohexenone

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047199A1 (en) * 1999-02-10 2000-08-17 Meiji Dairies Corporation Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases
JP2001089404A (en) * 1999-09-22 2001-04-03 Meiji Milk Prod Co Ltd Cyclohexenol derivative and medicine comprising the same
JP2003212811A (en) * 2002-01-22 2003-07-30 Meiji Milk Prod Co Ltd Method for producing cyclohexenone long-chain alcohol

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2299308C (en) * 1997-08-13 2008-03-25 Meiji Milk Products Co., Ltd. Cyclohexenone long-chain alcohol and medicament containing same
ATE450602T1 (en) * 2000-10-04 2009-12-15 Meiji Dairies Corp STEM CELL DIFFERENTIATION-INDUCING PROMOTERS
JP4861560B2 (en) * 2001-02-19 2012-01-25 株式会社明治 Treatment for diabetic complications
JP3836684B2 (en) * 2001-02-19 2006-10-25 明治乳業株式会社 Treatment for dysuria
WO2002094252A1 (en) 2001-05-24 2002-11-28 Meiji Dairies Corporation Preventive or remedy for diseases caused by cerebrovascular disturbances
US20040152766A1 (en) * 2001-05-31 2004-08-05 Au-Yeung Steven C.F. Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047199A1 (en) * 1999-02-10 2000-08-17 Meiji Dairies Corporation Use of a cyclohexenone long-chain alcohol for treating neurodegenerative diseases
JP2001089404A (en) * 1999-09-22 2001-04-03 Meiji Milk Prod Co Ltd Cyclohexenol derivative and medicine comprising the same
JP2003212811A (en) * 2002-01-22 2003-07-30 Meiji Milk Prod Co Ltd Method for producing cyclohexenone long-chain alcohol

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 134, Columbus, Ohio, US; abstract no. 261264, LUU, BANG ET AL: "Nerve cell growth-promoting cyclohexenols and pharmaceuticals containing them" XP002262863 *
MORI, KENJI ET AL: "Synthesis of sphingosine relatives. X. Synthesis of (2S, 3R, 4E)-1-O-(.beta.-D-glucopyranosyl)-N-[30'- (linoleoyloxy)triacontanoyl]-4-icosasphingenine, a new esterified cerebroside isolated from human and pig epidermis", LIEBIGS ANNALEN DER CHEMIE (1991), (6), 529-35, XP002262862 *
PATENT ABSTRACTS OF JAPAN vol. 2003, no. 11 5 November 2003 (2003-11-05) *

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180108669A (en) * 2016-01-22 2018-10-04 다이호야쿠힌고교 가부시키가이샤 Process for producing high purity cyclohexenone long-chain alcohol
JP2019504079A (en) * 2016-01-22 2019-02-14 大鵬薬品工業株式会社 Method for preparing high purity cyclohexenone long chain alcohol
EP3406586A4 (en) * 2016-01-22 2019-09-11 Taiho Pharmaceutical Co., Ltd. Manufacturing method for high-purity cyclohexenone long-chain alcohol
RU2729186C2 (en) * 2016-01-22 2020-08-05 Тайхо Фармасьютикал Ко., Лтд. Method of producing high-purity long-chain cyclohexenone alcohol
AU2017209644B2 (en) * 2016-01-22 2020-08-13 Taiho Pharmaceutical Co., Ltd. Manufacturing method for high-purity cyclohexenone long-chain alcohol
TWI728042B (en) * 2016-01-22 2021-05-21 日商大鵬藥品工業股份有限公司 Method for preparing high-purity cyclohexenone long-chain alcohol
KR102387362B1 (en) * 2016-01-22 2022-04-15 다이호야쿠힌고교 가부시키가이샤 Method for producing high-purity cyclohexenone long-chain alcohol
US11485696B2 (en) 2016-01-22 2022-11-01 Taiho Pharmaceutical Co., Ltd. Manufacturing method for high-purity cyclohexenone long-chain alcohol
RU2745062C2 (en) * 2016-02-03 2021-03-18 Тайхо Фармасьютикал Ко., Лтд. Producing method of long-chain alcohol of high purity cyclohexenone

Also Published As

Publication number Publication date
EP1608612A1 (en) 2005-12-28
CA2519178C (en) 2010-01-12
CA2519178A1 (en) 2004-10-14
US20060135818A1 (en) 2006-06-22
US7235700B2 (en) 2007-06-26
EP1608612B1 (en) 2008-02-27
DE60319439T2 (en) 2008-06-19
DE60319439D1 (en) 2008-04-10

Similar Documents

Publication Publication Date Title
Corey et al. Total synthesis of erythromycins. 5. Total synthesis of erythronolide A
JP2668759B2 (en) Intermediate for synthesis of 19-nor-vitamin D compound
DK2714710T3 (en) A process for the preparation of intermediates estetrol
JPH06172302A (en) Preparation of 19- nor vitamin d compound
Marshall et al. Total synthesis of (+-)-isonootkatone. Stereochemical studies of the Robinson annelation reaction with 3-penten-2-one
Johnson et al. Biomimetic polyene cyclizations. Participation of the (trimethylsilyl) acetylenic group and the total synthesis of the D-homosteroid system
Marshall et al. Stereocontrolled total synthesis of. alpha.-and. beta.-santonin
EP1608612B1 (en) Process for producing cyclohexenone long-chain alcohols
CA2107471C (en) Fluorine-containing vitamin d3 analogues
JP2000504335A (en) Biphenyl compounds and their use as estrogenic agents
Hwu et al. Silicon-directed decarbonylation of trimethylsilyl. beta.,. gamma.-enals by photolysis
JP4035332B2 (en) Process for producing cyclohexenone long chain alcohols
JP2793428B2 (en) Method for preparing 1α-hydroxy-secosterol compound
Cohen et al. Carbene anion formation from a dithioacetal anion bearing an allylic oxyanion substituent at the 2 position. Divergent behavior of the dianion in ether and THF
CN114560753B (en) Process for preparing hydroxy epoxy analogues
Hassner et al. Stereochemistry. XXXIX. Hydroboration of enol acetates
AU648073B2 (en) Cytotoxic bicyclo(7.3.1)tridec-4-ene-2,6-diyne compounds and process for the preparation thereof
Hojo et al. Diphenylsilane reduction of C= O and C= N bearing electron-withdrawing group in the presence of aluminum (III) chloride.
Haddadpour Studies toward Total Synthesis of Cyathane Diterpenoids
JP2680231B2 (en) Process for producing optically active 24-hydroxycholesterols
JP2975704B2 (en) Steroid derivatives
JPH07126246A (en) New intermediate for producing vitamin d derivative
Santiago et al. A Synthesis of 2, 2-Ethylenedioxy-6-ketones
Boukherroub et al. Unprecedented effects of the trimethylsilyl group on the reactivity of 3C-silylated silacyclopentenes and their derivatives
JPS61152675A (en) Production of dibenzo(b,e)oxepine derivative

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003715611

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2519178

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2006135818

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10550305

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2003715611

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10550305

Country of ref document: US

WWG Wipo information: grant in national office

Ref document number: 2003715611

Country of ref document: EP